Genomic Vision

GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition...

Molecular diagnostics,cytogenetics,genomics,dna replication,dna repair,genome maintenance,structural variation,fshd,and single dna molecule

Genomic vision operates in the Biotechnology research industry.

Genomic vision's revenue is 1m - 10m

Genomic vision has 11 - 50 employees.